Pathology of soft tissue sarcomas with emphasis on molecular diagnostic techniques

European Journal of Cancer, Supplement

Volumn 1, Issue 6 SPEC. ISS., 2003, Pages 205-210

  Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW; CONFERENCE PAPER; CYTOGENETICS; DIAGNOSTIC PROCEDURE; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL INFORMATION; MOLECULAR GENETICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE SARCOMA; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

EID: 3142587933     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(03)90025-5     Document Type: Conference Paper

References (29)

1. Langezaal S.M., Graadt van Roggen J.F., Cleton-Jansen A.M., Baelde J.J., Hogendoorn P.C.W. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer. 84:(4):2001;535-538
2. Graadt van Roggen J.F., Mooi W.J., Hogendoorn P.C.W. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol. 186:1998;3-7
3. Fletcher C.D.M. Haemangiopericytoma - A dying breed? Reappraisal of an 'entity' and its variants: a hypothesis. Curr Diagn Pathol. 1:1994;19-23
4. Nappi O., Ritter J.H., Pettinato G., Wick M.R. Hemangiopericytoma: histopathological pattern or clinicopathologic entity? Semin Diagn Pathol. 12:1995;221-232
5. Fletcher C.D., Gustafson P., Rydholm A., Willen H., Akerman M. Clinicopathologic reevaluation of 100 malignant fibrous histiocy-tomas: prognostic relevance of subclassification. J Clin Oncol. 19:(12):2001;3045-3050
6. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. 2002;IARC Press, Lyon
7. Graadt van Roggen J.F., Bovee J.V.M.G., Morreau J., Hogendoorn P.C.W. Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours. J Clin Pathol. 52:1999;481-489
8. Graadt van Roggen J.F., Bovee J.V.M.G., Van der Woude H.J., Hogendoorn P.C.W. An update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors. Curr Opin Rheumatol. 12:(1):2000;77-83
9. Peter M., Gilbert E., Delattre O. A multiplex real-time pcr assay for the detection of gene fusions observed in solid tumors. Lab Invest. 81:(6):2001;905-912
10. Congenital and inherited syndromes associated with bone and soft tissue tumours. Fletcher C.D.M., Unni K.K., Mertens F. World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone. 2002;348-367 IARC Press, Lyon
11. Heinrich M.C., Rubin B.P., Longley B.J., Fletcher J.A. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alternations. Hum Pathol. 33:2002;484-495
12. Kawai A., Woodruff J., Healy J.H., Brennan M.F., Antonescu C.R., Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 338:1998;153-160
13. Antonescu C.R., Kawai A., Leung D.H., Lonardo F., Woodruff J.M., Healey J.H., et al. Strong association of SYT SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol. 9:(1):2000;1-8
14. Panagopoulos I., Mertens F., Isaksson M., Limon J., Gustafson P., Skytting B., et al. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer. 31:(4):2001;362-372
15. Pelmus M., Guillou L., Hostein I., Sierankowski G., Lussan C., Coindre J.M. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18) (SYTSSX)-positive cases. Am J Surg Pathol. 26:(11):2002;1434-1440
16. May W.A., Arvand A., Thompson A.D., Braun B.S., Wright M., Denny C.T. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet. 17:(4):1997;495-497
17. Helman L., Fletcher J., Baker L. The best targets in sarcomas. 5th ed. Proc Am Assoc Cancer Res. 2002;194. Program
18. Nielsen T.O., West R.B., Linn S.C., Alter O., Knowling M.A., O'Connell J.X., et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet. 359:(9314):2002;1301-1307
19. Baelde H.J., Cleton-Jansen A.-M., Van Beerendonk H., Namba M., Bovee J.V.M.G., Hogendoorn P.C.W. High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol. 54:(10):2001;778-782
20. Oosterhuis J.W., Coebergh J.W., van Veen E.B. Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer. 3:(1):2003;73-77
21. Graadt van Roggen I.F. The histopathological grading of soft tissue tumours: current concepts. Curr Diagn Pathol. 7:(1):2001;1-7
22. Fletcher C.D., Berman J.J., Corless C., Gorstein F., Lasota J., Longley B.J., et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 33:(5):2002;459-465
23. Onda M., Matsuda S., Higaki S., Iijima T., Fukushima J., Yokokura A., et al. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer. 77:1996;71-78
24. Gorlick R., Huvos A.G., Heller G., Aledo A., Beardsley G.P., Healey J.H., et al. Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol. 17:(9):1999;2781-2788
25. Akatsuka T., Wada T., Kokai Y., Sawada N., Yamawaki S., Ishii S. Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma. Oncology. 60:(4):2001;361-366
26. Akatsuka T., Wada T., Kokai Y., Kawaguchi S., Isu K., Yamashiro K., et al. ErbB2 expression is correlated with increased survival of patients with osteosarcoma. Cancer. 94:(5):2002;1397-1404
27. Maitra A., Wanzer D., Weinberg A.G., Ashfaq R. Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas. Cancer. 92:(3):2001;677-683
28. Thomas D.G., Giordano T.J., Sanders D., Biermann J.S., Baker L. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. Clin Cancer Res. 8:(3):2002;788-793
29. Kilpatrick S.E., Geisinger K.R., King T.S., Sciarrotta J., Ward W.G., Gold S.H., et al. Clinicopathologic analysis of HER2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma. Mod Pathol. 14:(12):2001;1277-1283